Although many questions remain regarding the precise roles VGLL1 plays in promoting gene transcription, emerging evidence supports that effective targeting of this co-transcriptional activator may greatly benefit many patients suffering from different types of cancer. The gene discussed is VGLL1; the disease is cancer.